In recent years, several studies have confirmed that the cGAS-STING pathway has become a hotspot in anti-tumor immunology research (Kwon and Bakhoum, 2020; Li X et al., 2024; Xian et al., 2024). This evidence concerns the gene STING1 and neoplasm.